151
Views
3
CrossRef citations to date
0
Altmetric
Original Article

Cardiac function and tadalafil used for treating fetal growth restriction in pregnant women without cardiovascular disease

, , , , , , , , , , & show all
Pages 2460-2462 | Received 08 Jun 2017, Accepted 06 Feb 2018, Published online: 20 Feb 2018

References

  • Lees C, Valensise H, Black R, et al. The efficacy and fetal-maternal cardiovascular effects of transdermal glyceryl trinitrate in the prophylaxis of pre-eclampsia and its complications: a randomized double-blind placebo-controlled trial. Ultrasound Obstet Gynecol. 1998;12(5):334–338.
  • Picciolo C, Roncaglia N, Neri I, et al. Nitric oxide in the prevention of pre-eclampsia. Prenat Neonat Med. 2000;5(4):212–215.
  • Herraiz S, Pellicer B, Serra V, et al. Sildenafil citrate improves perinatal outcome in fetuses from pre-eclamptic rats. BJOG. 2012;119(11):1394–1402.
  • von Dadelszen P, Dwinnell S, Magee LA, et al. Sildenafil citrate therapy for severe early-onset intrauterine growth restriction. BJOG. 2011;118(5):624–628.
  • Maharaj CH, O’Toole D, Lynch T, et al. Effects and mechanisms of action of sildenafil citrate in human chorionic arteries. Reprod Biol Endocrinol. 2009;7:34.
  • Kubo M, Umekawa T, Maekawa Y, et al. Retrospective study of tadalafil for fetal growth restriction: impact on maternal and perinatal outcomes. J Obstet Gynaecol Res. 2017;43(2):291–297.
  • Kubo M, Tanaka H, Maki S, et al. Safety and dose-finding trial of tadalafil administered for fetal growth restriction: a phase-1 clinical study. J Obstet Gynaecol Res. 2017;43(7):1159–1168.
  • Zhao L, Mason NA, Morrell NW, et al. Sildenafil inhibits hypoxia-induced pulmonary hypertension. Circulation. 2001;104(4):424–428.
  • Daimon A, Kamiya CA, Iwanaga N, et al. Management of pulmonary vasodilator therapy in three pregnancies with pulmonary arterial hypertension. J Obstet Gynaecol Res. 2017;43(5):935–938.
  • Elkayam U, Gardin JM, Berkley R, et al. The use of Doppler flow velocity measurement to assess the hemodynamic response to vasodilators in patients with heart failure. Circulation. 1983;67(2):377–383.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.